Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 14Polycystic Ovary Syndrome 9Neoplasms 5Endometrial Neoplasms 3Prostatic Neoplasms 2Peripheral Nervous System Diseases 2Obesity 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Leukemia, Myeloid, Acute 2Leiomyoma 2Insulin Resistance 2Inflammation 2Infertility, Female 2Glioblastoma 2Diabetes Mellitus 2Colorectal Neoplasms 2Cognitive Dysfunction 2Cardiotoxicity 2Weight Gain 1Vomiting 1Venous Thromboembolism 1Vascular Malformations 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Stem Cell Transplant Complications 1

Interventions

Acupuncture Therapy 10Exercise 6Cryotherapy 6Paclitaxel 5Glutamine 4Surveys and Questionnaires 3Duloxetine Hydrochloride 3Dexamethasone 3Bortezomib 3Acetylcysteine 3Thioctic Acid 2Tablets 2Sodium Chloride 2Saline Solution 2Physical Therapy Modalities 2Low-Level Light Therapy 2Fish Oils 2Fatty Acids, Omega-3 2ziconotide 1pembrolizumab 1nicotinamide-beta-riboside 1glutamic acid diethyl ester 1enfortumab vedotin 1Yoga 1XELOX 1Vitamin D 1Vitamin B Complex 1Vitamin B 6 1Vitamin B 12 1Ultrasonic Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Peripheral Nervous System Diseases × Tablets × Clear all
NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Tanta University

Phase 2/3 Not yet recruiting
46 enrolled

Peripheral Nervous System Diseases

NCT07025005 2025-11-04

VRd MM Fibrate

Tanta University

Phase 4 Recruiting
44 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡